Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Affamed, Ascletis, Foresee, Gannex, Glaxosmithkline, Hightide, Humanigen, Immunitybio, Mezzion, Ocugen, Optimus, PCI, TLC, Vir.